لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Guan P; Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis Street, Genome, Singapore, 138672, Republic of Singapore., Chen J; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Mo C; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, PR China., Fukawa T; Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan., Zhang C; Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, P. R. China., Cai X; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Li M; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Hong JH; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Republic of Singapore., Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Republic of Singapore., Ng CCY; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Lee JY; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Wong SF; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Liu W; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Zeng X; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Wang P; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Xiao R; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China., Rajasegaran V; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Myint SS; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Lim AMS; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore., Yeong JPS; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore., Tan PH; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Republic of Singapore.; Division of Pathology, Singapore General Hospital, Singapore, Republic of Singapore.; Luma Medical Centre, Singapore, Republic of Singapore., Ong CK; Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore, Republic of Singapore., Xu T; Department of Urology, Peking University People's Hospital, Beijing, 100044, China., Du Y; Department of Urology, Peking University People's Hospital, Beijing, 100044, China., Bai F; Biomedical Pioneering Innovation Center (BIOPIC), Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking University, Beijing, 100871, China., Yao X; Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, P. R. China. yaoxin@tjmuch.com., Teh BT; Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis Street, Genome, Singapore, 138672, Republic of Singapore. teh.bin.tean@singhealth.com.sg.; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg.; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg.; SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore, Republic of Singapore. teh.bin.tean@singhealth.com.sg., Tan J; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. tanjing@sysucc.org.cn.; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore. tanjing@sysucc.org.cn.; Hainan Academy of Medical Science, Hainan Medical University, Haikou, PR China. tanjing@sysucc.org.cn.

المصدر: EMBO molecular medicine [EMBO Mol Med] 2024 Aug 09. Date of Electronic Publication: 2024 Aug 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

المؤلفون: Lee LS; Department of Urology, Sengkang General Hospital, Singapore, Singapore. lee.lui.shiong@singhealth.com.sg.; Duke-NUS Medical School, Singapore, Singapore. lee.lui.shiong@singhealth.com.sg., Sim AYL; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Ong CW; Department of Urology, Singapore General Hospital, Singapore, Singapore., Yang X; Department of Urology, Singapore General Hospital, Singapore, Singapore., Ng CCY; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Liu W; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Rajasegaran V; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Lim AMS; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Aslim EJ; Department of Urology, Singapore General Hospital, Singapore, Singapore., Ngo NT; Duke-NUS Medical School, Singapore, Singapore.; Department of Anatomic Pathology, Singapore General Hospital, Singapore, Singapore., Khor LY; Duke-NUS Medical School, Singapore, Singapore.; Department of Anatomic Pathology, Singapore General Hospital, Singapore, Singapore., Kanesvaran R; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Allen JCJ; Center for Quantitative Medicine/Office of Research, Duke-NUS Medical School, Singapore, Singapore., Tay KJ; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore, Singapore., Yuen JSP; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore, Singapore., Chong TW; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore, Singapore., Ho SSH; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore, Singapore., Teh BT; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Chua MLK; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.

المصدر: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Apr; Vol. 25 (4), pp. 803.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Lee LS; Department of Urology, Sengkang General Hospital, Singapore, Singapore. lee.lui.shiong@singhealth.com.sg.; Duke-NUS Medical School, Singapore, Singapore. lee.lui.shiong@singhealth.com.sg., Sim AYL; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Ong CW; Department of Urology, Singapore General Hospital, Singapore, Singapore., Yang X; Department of Urology, Singapore General Hospital, Singapore, Singapore., Ng CCY; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Liu W; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Rajasegaran V; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Lim AMS; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Aslim EJ; Department of Urology, Singapore General Hospital, Singapore, Singapore., Ngo NT; Duke-NUS Medical School, Singapore, Singapore.; Department of Anatomic Pathology, Singapore General Hospital, Singapore, Singapore., Khor LY; Duke-NUS Medical School, Singapore, Singapore.; Department of Anatomic Pathology, Singapore General Hospital, Singapore, Singapore., Kanesvaran R; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Allen JCJ; Center for Quantitative Medicine/Office of Research, Duke-NUS Medical School, Singapore, Singapore., Tay KJ; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore, Singapore., Yuen JSP; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore, Singapore., Chong TW; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore, Singapore., Ho SSH; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore, Singapore., Teh BT; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Chua MLK; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.

المصدر: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Apr; Vol. 25 (4), pp. 741-748. Date of Electronic Publication: 2022 Jan 28.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE

مواضيع طبية MeSH: Prostate-Specific Antigen* , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/surgery , Prostatic Neoplasms*/pathology, Male ; Humans ; Prostate/pathology ; Neoadjuvant Therapy/methods ; Androgen Antagonists/therapeutic use ; Receptors, Androgen ; Neoplasm Recurrence, Local/surgery ; Prostatectomy/methods